Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $0.38 Analyst target: $12.20 Upside: 3107.15%
Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using recombinant human protein. The company is headquartered in Burlington, Massachusetts.
See the full interactive analysis & chart →Informational only — not investment advice.